News Column

Baotou Dongbao 2013 Net Expected to Up 10%-22%

January 30, 2014

BAOTOU , January 30 , SinoCast -- Baotou Dongbao Bio-tech Co., Ltd. (SZSE: 300239) predicted net profit attributable to shareholders between CNY 39 million and CNY 43.5 million in 2013, rising 10.22% to 22.94% from a year earlier, because Beijing subsidiary is still in prophase development and needs great input, and gelatin prices sharply drop down, the performance of the subsidiary is worse then expectation. Hence, Baotou Dongbao will speed up cooperation with US companies to boost collagen exports to overturn dim situation.


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Sinocast Health Care & Medicine Beat (China)


Story Tools